Dexmedetomidine Hydrochlorid · 2,345 days since initial FDA posting
Brand: DEXMEDETOMIDINE
FDA lists Dexmedetomidine Hydrochlorid as Active Shortage (Gland Pharma Limited).
Availability on file: Available
Dexmedetomidine Hydrochloride Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dexmedetomidine Hydrochloride Injection
- Manufacturer
- Gland Pharma Limited
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42)
- Package NDC
- 66794-230-42
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Apr 10, 2020
- Last Updated
- Sep 29, 2025
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Marketed by Piramal Critical Care Inc.: 800-414-1901
Nearby, Other Dexmedetomidine Shortage Records
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Meitheal Pharmaceuticals, Inc.
Injection
Dexmedetomidine Hydrochloride Injection
HQ Specialty Pharma
Injection
FDA reason on file: Marketed by Piramal Critical Care Inc. General shortage guidance lives on the tracker hub.